DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



[Assessment of the antiphlogistic effect of naftifin-HCl in the UV-B erythema test]

Author(s): Kecskes A, Jahn P

Affiliation(s): Department Humanpharmakologie II, Schering AG Berlin.

Publication date & source: 1989-03, Hautarzt., 40(3):158-60.

Publication type: Clinical Trial; Controlled Clinical Trial

In a placebo-controlled double-blind comparative study conducted in 19 healthy volunteers, naftifin hydrochlorid cream was tested against clotrimazole 1%, clotrimazole 1%+hydrocortisone 1%, and various hydrocortisone preparations (0.5%; 1%; 2.5%) for erythema-suppressive effects. The anti-inflammatory effect of naftifine hydrochloride demonstrated earlier was confirmed in this study. The results prove a potency comparable to that of weak topical glucocorticosteroids.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017